Patient‐derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways
Malignant ascites is commonly produced in advanced epithelial ovarian cancer (EOC) and serves as unique microenvironment for tumour cells. Acellular ascites fluid (AAF) is rich in signalling molecules and has been proposed to play a role in the induction of chemoresistance. Through in vitro testing...
Saved in:
Main Authors: | Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff, Johannes Landskron, Lise‐Lotte Flage‐Larsen, Alexandra Gade, Line Bjørge, Alfonso Urbanucci, Kjetil Taskén |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13726 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Rare Case of Deep Pelvic Endometriosis Presenting with Serous Ascites and Infertility
by: Türkan Gürsu, et al.
Published: (2015-08-01) -
Fetal Ovarian Cyst Rupture Resulting in Transient Fetal Ascites
by: Ömer Kandemir, et al.
Published: (2014-08-01) -
Intraperitoneal Steroid Therapy for Recurrent Malignant Ascites in Advanced Cancer Patients: A Case Series
by: Nashid Islam, et al.
Published: (2025-01-01) -
Parameters of the Component Composition of the Body and Their Relationship with the Development of Ascites in Liver Cirrhosis
by: Yu. O. Zharikov, et al.
Published: (2024-08-01) -
Transjugular Portosystemic Shunting in Refractory Cirrhotic Ascites
by: Yu. V. Khoronko, et al.
Published: (2021-04-01)